Sign In
Buy BNGO
$1.30
+0.0400 (+3.17%)
At Close: Jun 03, 2026
Twitter And Discord Are Creating The New 'Boiler Room'
02:03pm, Wednesday, 22'nd Jul 2020
Twitter and Discord have individuals and groups promoting stocks reminiscent of the ideas portrayed in the older classic movie Boiler Room.
Twitter And Discord Are Creating The New 'Boiler Room'
10:03am, Wednesday, 22'nd Jul 2020
Twitter and Discord have individuals and groups promoting stocks reminiscent of the ideas portrayed in the older classic movie Boiler Room.
BioNano Genomics (BNGO) Receives a New Rating from a Top Analyst - Markets
04:49pm, Tuesday, 21'st Jul 2020
Maxim Group analyst Jason McCarthy assigned a Buy rating to BioNano Genomics (BNGO – Research Report) yesterday and set a
First large study in constitutional genetic diseases showed 100% concordance to all gold-standard cytogenetic testing methods combinedDemonstrates Bionano’s continued progress.
Maxim Group Thinks BioNano Genomics' Stock is Going to Recover - Markets
04:22pm, Saturday, 18'th Jul 2020
In a report released yesterday, Jason McCarthy from Maxim Group reiterated a Buy rating on BioNano Genomics (BNGO – Research
Bionano Genomics Data is Essential Part of the First Ever Complete Assembly of a Human X-Chromosome
10:02pm, Thursday, 16'th Jul 2020
SAN DIEGO, July 16, 2020 -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that the first ever complete assembly of a human chromosome utilized its genome imaging.
Company News for Jul 13, 2020
01:44pm, Monday, 13'th Jul 2020
Companies in the news are: BNGO, AMRX, ALT, EXPR
SAN DIEGO, July 09, 2020 -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has launched the new Bionano PrepTM SP Tissue and Tumor Kit, a DNA isolation kit.
Bionano Genomics, Inc. (BNGO) announced today that King’s College Hospital London, part of the NHS (National Health Service) in the UK, the Medical College of Wisconsin, and Yonsei University Hospit
Maxim Group Thinks BioNano Genomics' Stock is Going to Recover - Markets
01:09pm, Tuesday, 23'rd Jun 2020
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on BioNano Genomics (BNGO – Research
BioNano Genomics (BNGO) Receives a Buy from Oppenheimer - Markets
01:33am, Friday, 19'th Jun 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on BioNano Genomics (BNGO – Research Report),
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs
12:00am, Friday, 19'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 18)
ADC Therapeutics SA (NYSE:...
Bionano Genomics, Inc.'s (BNGO) CEO Dr. Erik Holmlin on Q1 2020 Results - Earnings Call Transcript
11:48pm, Thursday, 18'th Jun 2020
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2020 Results Earnings Conference Call June 18, 2020, 4:30 PM ET Company Participants Monique Kosse - Investor Relations
Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update
08:01pm, Thursday, 18'th Jun 2020
SAN DIEGO, June 18, 2020 -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and.
Bionano Announces Amendment to Proxy Statement for Annual Meeting of Stockholders
12:00pm, Thursday, 18'th Jun 2020
Bionano Genomics, Inc. (BNGO) today announced that on June 17, 2020 it filed an amendment to its Proxy Statement for its 2020 Annual Meeting of Stockholders in order to amend and supplement Proposal 1
